The fludarabine ( FLU)/melphalan (MEL) conditioning regimen containing FLU and high-dose MEL was analyzed in comparison with the BU/CY2 regimen to characterize oral mucositis ( OM) and risk factors. OM incidence significantly varied between BU/CY2 and FLU/ MEL ( 100 vs 78%, P = 0.004), but the incidence of severe OM grades 3-4 WHO and kinetics of OM were fully comparable. Patients with OM persisting on day +21 had more acute GVHD (68 vs 32%, P = 0.005), which tended to occur earlier than among those without such prolonged OM. Multivariate analysis showed significant dependency of acute GVHD on severity and prolonged duration of OM and significant correlation between OM severity and its prolonged duration. Body surface area-based dosing in the FLU/ MEL regimen led to a wide range of MEL doses administered per kilogram body weight (2.5-5.2 mg/kg, median 3.5). In multivariate analysis, MEL dose per kilogram of body weight was found to be a significant predictor of OM incidence and severity. Female gender and lower body mass index were less important variables than the fact that the actual dose of MEL administered per kilogram of body weight was relatively high when the dosage was calculated on the basis of body surface area. Bone Marrow Transplantation ( 2009) 44, 601-605; doi: 10.1038/bmt.2009.66; published online 6 April 2009
机构:
Nagoya Univ, Grad Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 4648601, JapanHokkaido Univ, Hokkaido Univ Hosp, Stem Cell Transplantat Ctr, Dept Hematol & Oncol,Kita Ku, Sapporo, Hokkaido 0608638, Japan
Suzuki, Ritsuro
Atsuta, Yoshiko
论文数: 0引用数: 0
h-index: 0
机构:
Nagoya Univ, Grad Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 4648601, JapanHokkaido Univ, Hokkaido Univ Hosp, Stem Cell Transplantat Ctr, Dept Hematol & Oncol,Kita Ku, Sapporo, Hokkaido 0608638, Japan
Atsuta, Yoshiko
Kawase, Takakazu
论文数: 0引用数: 0
h-index: 0
机构:
Aichi Canc Ctr, Div Immunol, Nagoya, Aichi 464, JapanHokkaido Univ, Hokkaido Univ Hosp, Stem Cell Transplantat Ctr, Dept Hematol & Oncol,Kita Ku, Sapporo, Hokkaido 0608638, Japan
Kawase, Takakazu
Ito, Yoichi M.
论文数: 0引用数: 0
h-index: 0
机构:
Hokkaido Univ, Grad Sch Med, Hokkaido Org Translat Res, Dept Clin Trial Management Biostat & Clin Data An, Sapporo, Hokkaido 0608638, JapanHokkaido Univ, Hokkaido Univ Hosp, Stem Cell Transplantat Ctr, Dept Hematol & Oncol,Kita Ku, Sapporo, Hokkaido 0608638, Japan
Ito, Yoichi M.
Yamashita, Takuya
论文数: 0引用数: 0
h-index: 0
机构:
Tokyo Metropolitan Komagome Hosp, Div Hematol, Tokyo, JapanHokkaido Univ, Hokkaido Univ Hosp, Stem Cell Transplantat Ctr, Dept Hematol & Oncol,Kita Ku, Sapporo, Hokkaido 0608638, Japan
Yamashita, Takuya
Fukuda, Takahiro
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, JapanHokkaido Univ, Hokkaido Univ Hosp, Stem Cell Transplantat Ctr, Dept Hematol & Oncol,Kita Ku, Sapporo, Hokkaido 0608638, Japan
Fukuda, Takahiro
Kumano, Keiki
论文数: 0引用数: 0
h-index: 0
机构:
Tokyo Univ Hosp, Dept Cell Therapy & Transplantat Med, Tokyo 113, JapanHokkaido Univ, Hokkaido Univ Hosp, Stem Cell Transplantat Ctr, Dept Hematol & Oncol,Kita Ku, Sapporo, Hokkaido 0608638, Japan
Kumano, Keiki
Iwato, Koji
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Red Cross Hosp, Div Internal Med 4, Hiroshima, Japan
Atom Bomb Survivors Hosp, Hiroshima, JapanHokkaido Univ, Hokkaido Univ Hosp, Stem Cell Transplantat Ctr, Dept Hematol & Oncol,Kita Ku, Sapporo, Hokkaido 0608638, Japan